|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 47/14 | (2013.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 9/0014 | (2013.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61P 17/06 | (2006.01) | ||
| A61P 17/06 | (2018.01) |
| (11) | Patento numeris | 3528818 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16919355.4 |
| Europos patento paraiškos padavimo data | 2016-10-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/058240 |
| Data | 2016-10-21 |
| (87) | Numeris | WO 2018/075071 |
| Data | 2018-04-26 |
| (72) |
HULL, Wade , US
VO, Ngoc Truc-Chi , CA
KING-SMITH, Dominic , US
|
| (73) |
Crescita Therapeutics Inc. ,
7560 Airport Road,
Unit 10, Mississauga, Ontario L4T 4H4,
CA
|
| (54) | PHARMACEUTICAL COMPOSITIONS |
| PHARMACEUTICAL COMPOSITIONS |